Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Accumulated Expenses (2021 - 2026)

Biohaven has reported Accumulated Expenses over the past 6 years, most recently at $41.7 million for Q1 2026.

  • Quarterly results put Accumulated Expenses at $41.7 million for Q1 2026, down 26.37% from a year ago — trailing twelve months through Mar 2026 was $41.7 million (down 26.37% YoY), and the annual figure for FY2025 was $104.3 million, up 102.56%.
  • Accumulated Expenses reached $41.7 million in Q1 2026 per BHVN's latest filing, down from $104.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $104.3 million in Q4 2025 and bottomed at $23.7 million in Q3 2022.
  • Median Accumulated Expenses over the past 5 years was $51.5 million (2024), compared with a mean of $54.1 million.
  • The largest annual shift saw Accumulated Expenses skyrocketed 122.05% in 2023 before it decreased 26.37% in 2026.
  • Over 5 years, Accumulated Expenses stood at $44.1 million in 2022, then fell by 9.66% to $39.8 million in 2023, then increased by 29.21% to $51.5 million in 2024, then soared by 102.56% to $104.3 million in 2025, then plummeted by 60.06% to $41.7 million in 2026.
  • Business Quant data shows Accumulated Expenses for BHVN at $41.7 million in Q1 2026, $104.3 million in Q4 2025, and $73.5 million in Q3 2025.